Placebo gargle | Rebamipide gargle | P | ||
Sex (Male/Female) | 7/5 | 7/5 | ||
Age (years) |
31-40 | 0 | 2 | χ2 = 6.8; df = 5; P = 0.238b |
41-50 | 0 | 2 | ||
51-60 | 5 | 5 | ||
61-70 | 2 | 2 | ||
71-80 | 4 | 1 | ||
81-90 | 1 | 0 | ||
Mean age (SD) | 65.9 (10.8) | 54.9 (11.5) | 0.077b | |
Primary site of cancer | ||||
Maxillary gingiva | 3 | 2 | χ2 = 3.7; df = 4; P = 0.522b |
|
Mandibular gingiva | 4 | 3 | ||
Tongue | 2 | 6 | ||
Oral floor | 2 | 1 | ||
Buccal mucosa | 1 | 0 | ||
Initial/relapse | 11/1 | 11/1 | ||
Stage of cancer | ||||
Stage I | 0 | 4 | χ2 = 6.0; df = 3; P = 0.125b |
|
Stage II | 4 | 4 | ||
Stage III | 1 | 1 | ||
Stage IV | 6 | 2 | ||
T size of cancer | ||||
T1 | 0 | 4 | χ2 = 7.2; df = 3; P = 0.065b |
|
T2 | 5 | 5 | ||
T3 | 3 | 2 | ||
T4 | 3 | 0 | ||
WBCa count at baseline, mean (SD) |
6.56 (1.83) | 5.80 (2.15) | 0.34b | |
Neutrophila count at baseline, mean (SD) |
3.94 (1.37) | 3.61 (2.15) | 0.48b |
a×103 cells/mm3.
|